SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-18-029798
Filing Date
2018-05-18
Accepted
2018-05-18 15:32:24
Documents
1
Period of Report
2018-05-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 tv494626_form4.html 4  
1 FORM 4 tv494626_form4.xml 4 3111
  Complete submission text file 0001144204-18-029798.txt   4600
Mailing Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632
Business Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632 201-464-2677
IMMUNE PHARMACEUTICALS INC (Issuer) CIK: 0001208261 (see all company filings)

IRS No.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BRAINSTORM CELL THERAPEUTICS, INC. 605 THIRD AVENUE, 34TH FLOOR NEW YORK NY 10158
Business Address
Fiorino Anthony S. (Reporting) CIK: 0001608901 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36602 | Film No.: 18846456